Cargando…
Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization
Haematuria is a known complication of prostatic malignancy and in severe cases can be unresponsive to bladder irrigation and endoscopic interventions. This report describes selective angiographic embolization as a means of haemorrhage control in adenocarcinoma of the prostate. A patient with locally...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243295/ https://www.ncbi.nlm.nih.gov/pubmed/30460001 http://dx.doi.org/10.1259/bjrcr.20150031 |
_version_ | 1783371949602242560 |
---|---|
author | Konczalik, Wojciech Acher, Peter Tam, Matthew Lodge, Richard |
author_facet | Konczalik, Wojciech Acher, Peter Tam, Matthew Lodge, Richard |
author_sort | Konczalik, Wojciech |
collection | PubMed |
description | Haematuria is a known complication of prostatic malignancy and in severe cases can be unresponsive to bladder irrigation and endoscopic interventions. This report describes selective angiographic embolization as a means of haemorrhage control in adenocarcinoma of the prostate. A patient with locally advanced prostatic adenocarcinoma and prior history of prostate brachytherapy, androgen deprivation therapy and chemotherapy presented with persistent haematuria that did not respond to endourological intervention. He was successfully treated with selective embolization of the vesical and prostatic vessels under fluoroscopic guidance. Angiographic embolization represents a safe and effective means of achieving haemostasis in patients not fit for surgerywho would otherwise be resigned to terminal care treatment. |
format | Online Article Text |
id | pubmed-6243295 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | The British Institute of Radiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-62432952018-11-20 Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization Konczalik, Wojciech Acher, Peter Tam, Matthew Lodge, Richard BJR Case Rep Case Report Haematuria is a known complication of prostatic malignancy and in severe cases can be unresponsive to bladder irrigation and endoscopic interventions. This report describes selective angiographic embolization as a means of haemorrhage control in adenocarcinoma of the prostate. A patient with locally advanced prostatic adenocarcinoma and prior history of prostate brachytherapy, androgen deprivation therapy and chemotherapy presented with persistent haematuria that did not respond to endourological intervention. He was successfully treated with selective embolization of the vesical and prostatic vessels under fluoroscopic guidance. Angiographic embolization represents a safe and effective means of achieving haemostasis in patients not fit for surgerywho would otherwise be resigned to terminal care treatment. The British Institute of Radiology 2016-11-02 /pmc/articles/PMC6243295/ /pubmed/30460001 http://dx.doi.org/10.1259/bjrcr.20150031 Text en © 2016 The Authors. Published by the British Institute of Radiology http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Case Report Konczalik, Wojciech Acher, Peter Tam, Matthew Lodge, Richard Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization |
title | Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization |
title_full | Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization |
title_fullStr | Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization |
title_full_unstemmed | Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization |
title_short | Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization |
title_sort | management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243295/ https://www.ncbi.nlm.nih.gov/pubmed/30460001 http://dx.doi.org/10.1259/bjrcr.20150031 |
work_keys_str_mv | AT konczalikwojciech managementofrefractoryhaematuriafollowingradiationtherapyandrecurrentadenocarcinomaoftheprostatewithfluoroscopicguidedselectivepelvicembolization AT acherpeter managementofrefractoryhaematuriafollowingradiationtherapyandrecurrentadenocarcinomaoftheprostatewithfluoroscopicguidedselectivepelvicembolization AT tammatthew managementofrefractoryhaematuriafollowingradiationtherapyandrecurrentadenocarcinomaoftheprostatewithfluoroscopicguidedselectivepelvicembolization AT lodgerichard managementofrefractoryhaematuriafollowingradiationtherapyandrecurrentadenocarcinomaoftheprostatewithfluoroscopicguidedselectivepelvicembolization |